Benefit of the Sequential Administration of Docetaxel after Standard FEC Regimen for Node-Positive Breast Cancer: Long-Term Follow-Up Results of the FNCLCC-PACS 01 Trial

Coudert, B., Campone, M., Spielmann, M., Symann, M., Eichler, F., Serin, D., Delozier, T., Romieu, G., Canon, J.-L., Orfeuvre, H., Piot, G., Petit, T., Chollet, P., Jerusalem, G., Audhuy, B., Veyret, C., Beauduin, M., Eymard, J.-C., Martin, A.-L., & Roche, H. (2009). Benefit of the Sequential Administration of Docetaxel after Standard FEC Regimen for Node-Positive Breast Cancer: Long-Term Follow-Up Results of the FNCLCC-PACS 01 Trial. Cancer Research, 69(24), 522S-522S. https://hdl.handle.net/2078.5/146901 (Original work published 2009)